Clinical Trial

A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to assess the effect of RO7204239 on insulin sensitivity versus placebo in participants with T2DM and obesity or overweight.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-14
Trial Details
NCT Number NCT07137585
Lead Sponsor Hoffmann-La Roche
Conditions Type 2 Diabetes Mellitus, Obesity, Overweight
Enrollment 30 participants
Start Date 2025-09-30
Primary Completion 2026-09-14 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-09